Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane and Cardiac Protection in High Risk Patients Undergoing Cardiac Surgery
NCT00821262Phase 4Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Sep 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevoflurane in cardiac surgery (2 arms), sponsored by Vita-Salute San Raffaele University. Primary endpoint: Composite endpoint or number of dead patients and/or number of patients requiring prolonged intensive care unit stay. Started Sep 2008; status: completed.
02
Drugs
sevoflurane
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on NCT00821262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821262.